Highbridge Capital Management LLC Bio Line Rx Ltd. Put Options Transaction History
Highbridge Capital Management LLC
- $435 Million
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BLRX
# of Institutions
36Shares Held
2.83MCall Options Held
75.1KPut Options Held
5.1K-
Cvi Holdings, LLC Wilmington, DE816KShares$2.99 Million4.05% of portfolio
-
Values First Advisors, Inc.166KShares$610,8670.02% of portfolio
-
Atria Wealth Solutions, Inc. New York, NY94.1KShares$345,4680.0% of portfolio
-
Lpl Financial LLC Fort Mill, SC92KShares$337,6400.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA87.2KShares$320,0790.0% of portfolio
About BioLineRx Ltd.
- Ticker BLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,524,500
- Market Cap $226M
- Description
- BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...